5-lipoxygenase activating protein reduction ameliorates cognitive deficit, synaptic dysfunction, and neuropathology in a mouse model of Alzheimer's disease

Biological Psychiatry (2013) - Comments
pubmed: 23683389 doi: 10.1016/j.biopsych.2013.04.009 issn: 0006-3223 issn: 1873-2402

Phillip F. Giannopoulos, Jin Chu, Yash B. Joshi, Margaret Sperow, Jin-Guo Li, Lynn G. Kirby, Domenico Praticò